BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26950525)

  • 1. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
    J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
    Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells.
    Zhang D; Al-Hendy M; Richard-Davis G; Montgomery-Rice V; Rajaratnam V; Al-Hendy A
    Fertil Steril; 2010 Oct; 94(5):1887-93. PubMed ID: 19819432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea extract inhibition of human leiomyoma cell proliferation is mediated via catechol-O-methyltransferase.
    Zhang D; Rajaratnam V; Al-Hendy O; Halder S; Al-Hendy A
    Gynecol Obstet Invest; 2014; 78(2):109-18. PubMed ID: 24942317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
    Wang J; Man GCW; Chan TH; Kwong J; Wang CC
    Cancer Lett; 2018 Jan; 412():10-20. PubMed ID: 29024813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.
    Zhang D; Al-Hendy M; Richard-Davis G; Montgomery-Rice V; Sharan C; Rajaratnam V; Khurana A; Al-Hendy A
    Am J Obstet Gynecol; 2010 Mar; 202(3):289.e1-9. PubMed ID: 20074693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
    Man GCW; Wang J; Song Y; Wong JH; Zhao Y; Lau TS; Leung KT; Chan TH; Wang H; Kwong J; Ng TB; Wang CC
    BMC Cancer; 2020 Oct; 20(1):964. PubMed ID: 33023525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
    Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs.
    Landis-Piwowar KR; Kuhn DJ; Wan SB; Chen D; Chan TH; Dou QP
    Int J Mol Med; 2005 Apr; 15(4):735-42. PubMed ID: 15754040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
    Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
    Moses MA; Henry EC; Ricke WA; Gasiewicz TA
    Cancer Prev Res (Phila); 2015 Mar; 8(3):249-57. PubMed ID: 25604133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study.
    Grandi G; Del Savio MC; Melotti C; Feliciello L; Facchinetti F
    Gynecol Endocrinol; 2022 Jan; 38(1):63-67. PubMed ID: 34658291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids.
    Al-Hendy A; Segars JH; Taylor HS; González F; Siblini H; Zamah M; Alkelani H; Singh B; Flores VA; Christman GM; Johnson JJ; Huang H; Zhang H
    BMJ Open; 2024 Jan; 14(1):e078989. PubMed ID: 38216200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
    Siblini H; Al-Hendy A; Segars J; González F; Taylor HS; Singh B; Flaminia A; Flores VA; Christman GM; Huang H; Johnson JJ; Zhang H
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.